FDA Clearance Tracker · P200039-S013
Shockwave Intravascular System with the C2/C2+ Coronary IVL Catheter
Last checked: Nov 20, 2026Latest source record: Oct 24, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2024
Approved
Time to decision
260 days
Received Feb 7, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P200039-S013
- Device name
- Shockwave Intravascular System with the C2/C2+ Coronary IVL Catheter
- Applicant
- Shockwave Medical, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Feb 7, 2024
- Decided
- Oct 24, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P200039
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
a new Shockwave Medical catheter manufacturing site located at SWAV CR SRL Coyol Free Zone, Building B50.B., El Coyol, Alajuela, Costa Rica and a new Steris AST sterilization facility located at Coyol Free Zone, Building B16, Alajuela, Costa Rica.
Source documents
Other decisions for Shockwave Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter510(k)
K262201 · Decided Jul 27, 2026 · 28 days after receipt
Device type: Percutaneous Catheter, Ultrasound (PPN) · Cardiology
K243757 · Decided May 2, 2025 · 147 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K242213 · Decided Sep 27, 2024 · 60 days after receipt
Device type: Percutaneous Catheter, Ultrasound (PPN) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.